Apyx Medical Corporation Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Apyx Medical Corp. (APYX) Tops Q2 EPS by 7c, Revenues Beat
August 10, 2020 7:17 AM EDTApyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of ($0.14), $0.07 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $1.96 million.
Second Quarter 2020 Financial Summary:
Total revenue of $4.3 million, down 35% year-over-year.Advanced Energy revenue of $2.9 million, down 46% year-over-year.OEM revenue of $1.4 million, up 10% year-over-year.GAAP net loss of $4.7 million, compared to total GAAP net loss of $4.3 million for the second quarter of 2019.Adjusted EBITDA loss of $4.9 million, compared to adjusted EBITDA loss of $3.6 million for the second... More